BioMed Research International

BioMed Research International / 2016 / Article

Corrigendum | Open Access

Volume 2016 |Article ID 3017536 | https://doi.org/10.1155/2016/3017536

A. Macià, J. Herreros, R. M. Martí, C. Cantí, "Corrigendum to “Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma”", BioMed Research International, vol. 2016, Article ID 3017536, 1 page, 2016. https://doi.org/10.1155/2016/3017536

Corrigendum to “Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma”

Received24 Apr 2016
Accepted25 May 2016
Published17 Aug 2016

In the article titled “Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma” [1], there was an error in the “Acknowledgments” section, which should be corrected as follows.

This work was supported by Instituto de Salud Carlos III/Fondo Europeo de Desarrollo Regional (FEDER), “A way to build Europe” (PI1200260 to R. M. Martí, PI070357 to C. Cantí, and PI1301980 to J. Herreros), and a grant from Fundació la Marató de TV3 (Subproject 201331-31 to R. M. Martí).

References

  1. A. Macià, J. Herreros, R. M. Martí, and C. Cantí, “Calcium channel expression and applicability as targeted therapies in melanoma,” BioMed Research International, vol. 2015, Article ID 587135, 7 pages, 2015. View at: Publisher Site | Google Scholar

Copyright © 2016 A. Macià et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views490
Downloads195
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.